The prevalence of LVH in acromegaly patients has been estimated at between 50 and 80% and has been shown to be determined by the patient's age, duration of disease, BMI, SBP, gender, and GH/IGF-1 levels (Vitale G et al.)[4]. This evidence concerns the gene GH1 and acromegaly.